CORTICOTROPIN THERAPY IN MYASTHENIA GRAVIS - EFFECTS, INDICATIONS, AND LIMITATIONS

被引：40

作者：

NAMBA, T

BRUNNER, NG

SHAPIRO, MS

GROB, D

机构：

来源：

关键词：

D O I：

10.1212/WNL.21.10.1008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1008 / &

共 78 条

[1]

BRYAN WM, 1954, OBSTET GYNECOL, V4, P339

CAPE, CA ;

UTTERBACK, RA .

[3]

CARMENA VA, 1961, REV CLIN ESP, V82, P195

[4]

CORBINO D, 1962, RIV NEUROBIOL, V8, P501

[5]

Day J, 1967, Nurs Times, V63, P1695

[6]

DITTLER EL, 1952, NEW YORK STATE J MED, V52, P1565

[7]

Dougherty TF, 1943, P SOC EXP BIOL MED, V53, P132, DOI 10.3181/00379727-53-14219P

FRENKEL, M ;

EHRLICH, EN .

[9] PLACE OF CORTICOTROPIN IN THE TREATMENT OF MYASTHENIA GRAVIS [J].

FREYDBERG, LD .

[10] EMG ANALYSIS OF MYASTHENIC ACTH DETERIORATION [J].

GANDIGLI.G ;

PINELLI, P .